Evidence map›Paper›PMID 33026236›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis.

Xinh-Xinh Nguyen, Tetsuya Nishimoto, Takahisa Takihara, Logan Mlakar, Amy D Bradshaw, Carol Feghali-Bostwick

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Differential expression of members of SOX family of transcription factors in failing human hearts.Translational research : the journal of laboratory and clinical medicine · 2022
    Pooled it
  2. Review
  3. Review
  4. From copper imbalance to immunometabolic remodeling: cuproptosis-related vulnerability and therapeutic hypotheses in autoimmune diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Xinh-Xinh NguyenDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Tetsuya NishimotoDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Takahisa TakiharaDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Logan MlakarDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Amy D BradshawDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Carol Feghali-BostwickDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Medical University of South Carolina · USTokai University · JP

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Pulmonary Focused Foundations in Innovation and Scholarship (PuFFInS)T32HL144470 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Carol A. Feghali-Bostwick · 2019 to 2026
$2.6M
Role of pericytes in scleroderma skin and lung fibrosisR01HL133751 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI FEGHALI-BOSTWICK, CAROL A., SCHNAPP, LYNN M · 2017 to 2020
$2.0M
Peptide Based Therapy for Lung FibrosisR42HL127802 · NHLBI · NOVICI BIOTECH, LLC · PI FEGHALI-BOSTWICK, CAROL A., PADGETT, HAL S · 2015 to 2017
$1.7M
IGF-II regulates lung fibrosis in sclerodermaR01HL153195 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2020 to 2023
$1.5M
Mechanism of Action of Anti-Fibrotic PeptideR01HL121262 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2017 to 2020
$1.5M
Scleroderma Twin Study and analysis of Estrogen in patients with dcSScK24AR060297 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FEGHALI-BOSTWICK, CAROL A. · 2013 to 2025
$1.4M
HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) R01 HL 133751NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NHLBI NIH HHS R01 HL121262NHLBI NIH HHS R01 HL133751NHLBI NIH HHS R01 HL153195NHLBI NIH HHS R42 HL127802NHLBI NIH HHS T32 HL144470NIAMS NIH HHS K24 AR060297
6 · The paper itself

Abstract

Pulmonary fibrosis is one of the important causes of morbidity and mortality in fibroproliferative disorders such as systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF). Lysyl oxidase (LOX) is a copper-dependent amine oxidase whose primary function is the covalent crosslinking of collagens in the extracellular matrix (ECM). We investigated the role of LOX in the pathophysiology of SSc. LOX mRNA and protein levels were increased in lung fibroblasts of SSc patients compared with healthy controls and IPF patients. In vivo, bleomycin induced

Indexed as

AnimalsAntibiotics, AntineoplasticBleomycinCase-Control StudiesExtracellular MatrixFibroblastsHumansInterleukin-6LungMaleMiceMice, Inbred C57BLProtein-Lysine 6-OxidasePulmonary FibrosisScleroderma, SystemicAntibiotics, AntineoplasticBleomycinInterleukin-6Protein-Lysine 6-Oxidaseextracellular matrix (ECM)fibrosisidiopathic pulmonary fibrosis (IPF)lysyl oxidase (LOX)systemic sclerosis (SSc)

Identifiers

PMID33026236
PMCPMC7847064
OpenAlexW3091982350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.